Given the Weizmann Institute’s worldwide renown for discoveries and insights in immunology, and how the immune system identifies pathogens and overcomes them—or fails to overcome them—our scientists are uniquely positioned to advance understanding and chart new paths forward amidst the coronavirus pandemic.
In one highly promising project, our scientists are using computational and experimental tools to rapidly design antibodies that will target the SPIKE protein in the coronavirus and thereby neutralize infection. Another scientist is applying new insights from another set of animal-borne viruses to COVID-19. And others are exploring the intricate mechanisms of the immune system and ways in which our healthy cells mount counter-attacks to deadly viruses.
our latest research in these areas
- Why COVID-19 kills, or doesn’t
Weizmann technology maps the difference between coronavirus patients
- Prof. Noam Sobel: Sniffing out COVID-19
Every disease has an odor and Prof. Noam Sobel's lab is using their "electronic nose" to find a new way of diagnosing COVID-19 patients.
- Coronavirus by the numbers
A measured approach to understanding—and defeating—the COVID-19 pandemic
- A+ in digital science education
Weizmann system uses AI to personalize remote classroom learning
- A sniff test for coronavirus?
SmellTracker could support early COVID-19 diagnosis
- Navigating the new normal
Leveraging math, potential exit strategy aims to maintain health, safely reboot economy
- A science-based exit strategy for COVID-19
Profs. Uri Alon and Ron Milo suggest a way to leave isolation but remain safe. And it's all based on scientific models.
- Dr. Ori Avinoam: Blocking the virus’s first steps
Researching ways to block the very first thing the coronavirus does - fusing its membrane with that of the host cell.
- Dr. Ziv Shulman: Recovered patients to the rescue
Dr. Shulman fishes out the correct antibodies from recovered patients of the coronavirus and researches the ability of these antibodies to provide short-term immunity and a cure.
Towards a drug against COVID-19
Co-led by Dr. Nir London, global consortium aims to accelerate drug development
- Designing a solution
Computational approach may lead to a future treatment for coronavirus
- How do viruses infect?
Deciphering the dynamic that hijacks our health
- New weapon in the war on animal-borne viruses
Engineered molecule could lead to treatments for viruses that cross over from animals to humans
- Learning from lethal viruses
Insights on Ebola, arenaviruses pave way for Dr. Ron Diskin's next target—coronavirus